# OnCo record gadolinium-contrast-kidney-impairment (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/gadolinium-contrast-kidney-impairment/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "gadolinium-contrast-kidney-impairment" ;
  schema:name "Gadolinium contrast for MRI in kidney impairment: NSF risk by agent group"@en ;
  schema:alternateName "gadolinium and kidneys"@en, "MRI contrast and kidney disease"@en, "nephrogenic systemic fibrosis"@en, "NSF"@en, "GBCA"@en, "GBCM"@en, "gadolinium-based contrast agent"@en, "eGFR before MRI"@en, "MRI dye kidneys"@en, "gadolinium dialysis"@en ;
  schema:description "Many MRI scans for cancer use a dye containing gadolinium. Older types could cause a rare, serious scarring disease (nephrogenic systemic fibrosis) in people with very weak kidneys. The types used for most scans today carry a very low risk, so an important scan should not be refused because of the kidneys. Tell the team if you have kidney disease, are on dialysis, or are pregnant or breastfeeding."@en ;
  schema:url <https://onco.cc/protocols/gadolinium-contrast-kidney-impairment/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:related <https://onco.cc/protocols/iodinated-contrast-kidney-and-metformin/>, <https://onco.cc/protocols/contrast-reaction-history-and-premedication/>, <https://onco.cc/protocols/mri-safety-screening-implants/> ;
  onco:technologies <https://onco.cc/technologies/gadolinium-based-contrast-agents/>, <https://onco.cc/technologies/mri/> ;
  onco:drugs <https://onco.cc/drugs/gadobutrol/>, <https://onco.cc/drugs/gadoterate-meglumine/>, <https://onco.cc/drugs/gadoteridol/>, <https://onco.cc/drugs/gadopiclenol/>, <https://onco.cc/drugs/gadobenate-dimeglumine/>, <https://onco.cc/drugs/gadoxetate-disodium/>, <https://onco.cc/drugs/gadodiamide/> .